{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:02:11Z","timestamp":1791860531987,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.imlet.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T18:55:16Z","timestamp":1440183316000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products"],"prefix":"10.1016","volume":"167","author":[{"given":"Takanori","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoo Don","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Mi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang Hong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Higashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2015.08.008_bib0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mnfr.200500008","article-title":"Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection","volume":"49","author":"Ahmed","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.imlet.2015.08.008_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0009-8981(03)00113-X","article-title":"Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood","volume":"332","author":"Ahn","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.imlet.2015.08.008_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hyb.1999.18.371","article-title":"Production and characterization of isotype-specific monoclonal antibodies to bovine brain Rab GDI","volume":"18","author":"Ha","year":"1999","journal-title":"Hybridoma"},{"key":"10.1016\/j.imlet.2015.08.008_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mvr.2013.08.010","article-title":"Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells","volume":"90","author":"Higashimoto","year":"2013","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.imlet.2015.08.008_bib0025","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.04943.x","article-title":"Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis","volume":"22","author":"Hyogo","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.imlet.2015.08.008_bib0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2840-13-60","article-title":"Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression","volume":"13","author":"Ishibashi","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.imlet.2015.08.008_bib0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10238-006-0115-6","article-title":"Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes","volume":"6","author":"Jinnouchi","year":"2006","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.imlet.2015.08.008_bib0040","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2337\/db12-1608","article-title":"DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy","volume":"62","author":"Kaida","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2015.08.008_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc14-1435","article-title":"Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function","volume":"38","author":"Kajikawa","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.imlet.2015.08.008_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-014-0162-3","article-title":"Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE","volume":"14","author":"Matsui","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.imlet.2015.08.008_bib0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phrs.2011.02.003","article-title":"Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis","volume":"63","author":"Matsui","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.imlet.2015.08.008_bib0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajpath.2012.09.016","article-title":"Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression","volume":"182","author":"Ojima","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2015.08.008_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/labinvest.2014.5","article-title":"DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice","volume":"94","author":"Ojima","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.imlet.2015.08.008_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12013-007-0021-x","article-title":"Novel inhibitors of glycation and AGE formation","volume":"48","author":"Rahbar","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.imlet.2015.08.008_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-5922.2010.00177.x","article-title":"Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects","volume":"30","author":"Tahara","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.imlet.2015.08.008_bib0080","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.2337\/dc12-0087","article-title":"Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography","volume":"35","author":"Tahara","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.imlet.2015.08.008_bib0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF03401969","article-title":"Immunological detection of a novel advanced glycation end-product","volume":"7","author":"Takeuchi","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.imlet.2015.08.008_bib0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnen\/59.12.1094","article-title":"Neurotoxicity of advanced glycation end-products for cultured cortical neurons","volume":"59","author":"Takeuchi","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.imlet.2015.08.008_bib0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/labinvest.2010.62","article-title":"Immunological detection of fructose-derived advanced glycation end-products","volume":"90","author":"Takeuchi","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.imlet.2015.08.008_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1755-5922.2011.00264.x","article-title":"Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects","volume":"30","author":"Ueda","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.imlet.2015.08.008_bib0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1271\/bbb.60497","article-title":"Detection and determination of glyceraldehyde-derived pyridinium-type advanced glycation end products in streptozotocin-induced diabetic rats","volume":"71","author":"Usui","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2015.08.008_bib0110","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.2337\/diab.45.3.S65","article-title":"Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors","author":"Vlassara","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2015.08.008_bib0115","doi-asserted-by":"crossref","first-page":"20213","DOI":"10.1074\/jbc.M602110200","article-title":"Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression","volume":"281","author":"Yamagishi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2015.08.008_bib0120","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.diabres.2007.01.030","article-title":"Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells","volume":"77","author":"Yamamoto","year":"2007","journal-title":"Diabetes Res. Clin. Pract."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T05:22:26Z","timestamp":1655616146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815300225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0165247815300225"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.08.008","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}